Amend Surgical, Inc.

Amend Surgical, Inc. is a US-based medical technology company specializing in innovative adhesive solutions for oral wound care and surgical applications, focused on enhancing patient outcomes through advanced product offerings. Founded in 2015 and headquartered in Alachua, US, Amend Surgical, Inc. develops proprietary adhesive technologies for use in healthcare.

The company has engaged in five notable deals and received funding in April 2023, enabling significant advancements in their product lines. CEO Robby Lane leads the company, which has remained focused on its original mission without any known pivots or changes in business strategy. Amend Surgical, Inc. specializes in advanced adhesive technologies designed for oral wound care and other surgical applications.

Their flagship product, Amend Tissue Tape, is a bio-inspired, long-lasting adhesive that utilizes a natural glue and barrier system to adhere to and protect wounds during the oral healing process. The company also offers a biocompatible hydrogel and chitosan-based glue for reconnecting peripheral nerves, along with unique implants that merge bioactive glass and demineralized allograft bone for orthopedic and spinal fusion procedures. Their target market includes healthcare providers in the dental and surgical sectors across the United States. Amend Surgical operates on a business-to-business model, primarily serving healthcare institutions and professionals in surgical and dental care.

Revenue is generated through direct sales of proprietary products, including Amend Tissue Tape and other technologies, to hospitals, clinics, and surgical centers, often involving bulk orders. The company is actively pursuing partnerships to expand distribution channels and enhance its market reach without disclosing specific pricing information for their products. In April 2023, Amend Surgical, Inc. received a grant funding amount of USD 370,000 from MPWRM Resource Center, which will be utilized for scaling their suture-less solution for the repair of peripheral nerves.

The company is focused on designing and launching new products aimed at enhancing oral wound care solutions, with plans for expansion into additional healthcare markets across the United States and potentially beyond within the coming years.